Changes in Social Participation of Persons Affected by Leprosy, Before and After Multidrug Therapy, in an Endemic State in Eastern India

Senthilkumar Ramasamy, Pitchaimani Govindharaj, Archana Kumar, Karthikeyan Govindasamy, Annamma S John


Purpose: In general, multidrug therapy (MDT) completion rate and the change in disability levels before and after medical treatment are reported as outcomes in leprosy programmes. Changes in activity and social participation levels are rarely reported, possibly because the parameters are more difficult to measure. The study aimed to assess and evaluate the changes in social participation among leprosy-affected persons after completion of MDT.

Method: An observational study was conducted among 108 newly-diagnosed leprosy- affected clients, who were registered at the Leprosy Referral Hospital in Champa, Chhattisgarh. Their disability levels pre- and post- MDT were assessed using the WHO Disability Grading, and their social participation level was assessed using the Participation Scale.

Results: Of the 108 clients registered during the study period, 90 completed the full course of MDT and were included in the analysis. The majority of these 90 clients or 83% were multibacillary and 23% had Grade 2 disability at the time of diagnosis. At the end of MDT with steroids therapy for reaction and neuritis, the proportion of clients with no participation restriction increased from 76% to 93%. Clients with visible impairments had more restriction as compared to those with no deformity or no visible deformity, before and after MDT. Among those with visible impairments, 78% had mild to severe restriction before MDT and it declined to 26% on completion of treatment.

Conclusion: Presence of Grade 2 disability at the time of diagnosis was significantly associated with participation restriction. MDT and steroid therapy for management of reaction and/or neuritis improves the participation level of leprosy-affected clients, suggesting that early detection and appropriate management would reduce their risk of participation restriction.


Leprosy; disability; participation restriction; multi drug therapy

Full Text:



Barbosa JC, Ramos AN Jr, Alencar MJ, Castro CG (2008). Post-treatment of Leprosy in Ceará: activity and functional limitation, safety awareness and social participation. Rev Bras Enferm; 61: 727-33. PMid:19009115

Brandsma JW, Van Brakel WH (2003). WHO disability grading: operational definitions. Lepr Rev; 74: 366-373.

De Castro LE, da Cunha AJ, Fontana AP, de Castro Halfoun VL, Gomes MK (2014). Physical disability and social participation in patients affected by leprosy after discontinuation of multidrug therapy. Lepr Rev; 85: 208-17.

De Souza VTC, Da Silva WM Jr, De Jesus AMR, De Oliveira DT, Raptis HA, De Freitas PHL, Schneiberg S (2016). Is the WHO Disability Grading System for Leprosy Related to the Level of Functional Activity and Social Participation? Lepr Rev; 87: 191-200.

Jain M, Singh N, Bhatia A, Arora VK (2000). Histological assessment of dermal nerve damage occuring during multidrug therapy for leprosy. Int J Lepr; 68: 167-71

Malviya GN (2014). Disabilities in leprosy-The new concepts. Indian J Lepr; 86: 121-27.

Nardi SM, Paschoal VD, Zanetta DM (2011). Social participation of people affected by leprosy after discontinuation of multidrug therapy. Lepr Rev; 82: 55-64.

Senturk V, Sagduyu A (2004). Psychiatric disorders and disability among leprosy patients; a review. Turk Psikiyatri Derg; 15: 236-43.

Singh S, Sinha AK, Banerjee BG, Jaswal N (2009). Participation level of the leprosy patients in society. Indian J Lepr; 181: 181-187.

Sinha A, Kushwaha AS, Kotwal A, Sanghi S, Verma AK (2010). Stigma in leprosy: Miles to go!. Indian J Lepr; 82: 137-145.

Stigter DH, Geus L, Heynders ML (2000). Leprosy: between acceptance and segregation. Community behaviour towards persons affected by leprosy in eastern Nepal. Lepr Rev; 71: 492-98. PMid:11201904

Van Brakel WH, Anderson AM, Mutaktar RK, Bakirtzief Z, Nicholls PG, Raju MS, Das-Pattanayak RK (2006). The Participation Scale: Measuring a key concept in public health. Disabil and Rehabil; 28: 193-203. PMid:16467054

Van Brakel WH, Officer A (2008). Approaches and tools for measuring disability in low and middle-income countries. Lepr Rev; 79: 50-64.

Van Brakel WH, Sihombing B, Djarir H, Beise K, Kusumawardhani L, Yulihane R, Kurniasari I, Kasim M, Kesumaningsih KI, Wilder-Smith A (2012). Disability in people affected by leprosy: the role of impairment, activity, social participation, stigma and discrimination. Global health action; 5: 18394. PMid:22826694 PMCid:PMC3402069

World Health Organisation - WHO (2013). Frequently asked questions on leprosy. Regional Office for South-East Asia, New Delhi. Available at: [Accessed on 14 Jul 2018].

World Health Organisation - WHO (2016). Global leprosy update, 2015: time for action, accountability and inclusion. Wkly Epidemiol Rec; 91: 405-20.


Copyright (c) 2019 Senthilkumar Ramasamy, Pitchaimani Govindharaj, Archana Kumar, Karthikeyan Govindasamy, Annamma S John

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Supported by:


© Disability, CBR & Inclusive Development